Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases

BACKGROUND: Therapies for metabolic diseases are numerous, yet improving insulin sensitivity beyond that induced by weight loss remains challenging. Therefore, search continues for novel treatment candidates that can stimulate insulin sensitivity and increase weight loss efficacy in combination with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonne, Nina, Karsdal, Morten A., Henriksen, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085567/
https://www.ncbi.nlm.nih.gov/pubmed/33166741
http://dx.doi.org/10.1016/j.molmet.2020.101109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085567/
https://www.ncbi.nlm.nih.gov/pubmed/33166741
http://dx.doi.org/10.1016/j.molmet.2020.101109

Ejemplares similares